1 Result(s)

Article

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model

Immunochemotherapy, the combined use of immunotherapy and chemotherapy, has demonstrated great promise in several cancers. LTX-315 is an oncolytic peptide with potent immunomodulatory properties designed for t...

Ketil A. Camilio, Meng-Yu Wang, Brynjar Mauseth, Stein Waagene… in Breast Cancer Research (2019)